Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine
Jazz Pharmaceuticals' strategy is starting to pay dividends.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Health & Medicine
The other Pillay at the Geneva pharmacy
A surname coincidence in Switzerland brings back memories of my parents’ generation, and the opportunities opened to some women and denied to others.
- Journalist met Judge Navi Pillay by coincidence in Geneva pharmacy
- Judge Pillay's Nobel Peace Prize in 2026 recalled journalist's parents' generation
- Journalist's mother insisted on her education, unlike her grandmother's denied schooling
IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13
Introducing the human papillomavirus (HPV) vaccine at ages 9 to 10 years rather than 11 to 12 years leads to a meaningful difference in initiation and completion of the vaccine series, including…
How blocking immune cell signals could make brain tumors easier to remove
In a new study published in Cancer Cell, researchers at VIB-KU Leuven reduced the spread of glioblastoma by interrupting specific interactions between the brain's immune cells and tumor cells.
Ebola: Borno Govt constitutes rapid response team
Borno State Government has put in place a Rapid Response Team to boost its readiness for any suspected outbreak of Ebola Virus Disease in the state.
Initial treatment for lower back pain is associated with subsequent risk of opioid use disorder and overdose
Adults on Medicaid who began treatment for a new bout of low back pain with a higher-dose opioid prescription were about two and a half times as likely to later show signs of opioid use disorder or…
Summer's produce outbreaks expose gaps in FDA oversight of imported food
Most fresh fruits and vegetables imported into the United States come from foreign facilities that federal inspectors have rarely, if ever, visited, a new investigation finds.